On May 21, Benefits Canada hosted a webinar to explore the coronavirus pandemic’s impact on chronic disease in the workplace, as well as how virtual solutions can support employee health through this unprecedented time. All employers are currently facing the same concerns, said Marie-Josée Le Blanc, a partner at Mercer, during the webinar. Pointing to the 2019 […]
Aon has introduced an interactive online tool that forecasts the impact of the coronavirus on employee populations across Canada, aiming to help employers anticipate the effect on their benefits plan costs, absenteeism and potential requirements for shifting work operations. “COVID-19 has brought on uncertainties in many aspects of our lives and this application will help […]
In the midst of the coronavirus crisis, virtual health care is taking centre stage. But Ontario Power Generation was ahead of the curve, introducing a pilot project in 2019 to help employees with high mental-health incidences and absenteeism rates minimize their sick leave usage. The pilot, implemented on July 1, 2019, provides about 500 hydro […]
In 2019, Telus Communications Inc. bumped up its combined lifetime plan maximum per employee for fertility benefits to $15,000 for both treatment procedures and drugs. “More than anything, it’s just recognizing that we want to be a good place for women to work,” says Carol Craig, director of pensions and benefits at Telus. Generally, Canadian […]
The coronavirus pandemic could reduce employer health-care costs by as much as four per cent in 2020 as medical care for non-infected patients has declined, according to a new analysis by Willis Towers Watson. The analysis of large, self-funded U.S.-based employers is an update to a similar study conducted in March that projected employer costs […]
Private drug plans saw a slight uptick in costs in 2019 due to the increased use of specialty drugs and higher price points for traditional medications, according to Express Scripts Canada’s annual drug trends report. The report found private drug plan spending per claimant increased one per cent over 2018’s figures. Plans’ annual spend per claimant on […]
As U.S. employers look to keep their workers safe and healthy in the face of the global pandemic, they could see their health-care benefits costs jump by as much as seven per cent this year as a result of coronavirus-related testing and treatment, according to an actuarial analysis of self-funded employers by Willis Towers Watson. […]
On March 3, the 2020 Employers Cancer Care Summit featured sessions on cancer-related issues and opportunities tied to benefits plans and the workplace. Many perspectives required when covering cancer drugs on benefits plans While treatment options for cancer are more than they used to be, many still aren’t covered under the public health-care system, according to Tim […]
Over the past couple of years, I’ve been relentlessly pestered by my dentist’s office. I’ve lost track of the frequency of texts, emails and phone calls. When the overt neediness increased even more at the end of last year, I realized it had barely been six months since our last date. Is it just me […]
Taking a look at private drug plans in 2020, a number of trends are converging: spending on specialty drugs is continuing its upward trajectory, advancements in a number of lifechanging therapies are in the pipeline and policy developments are coming at both the federal and provincial levels. In the face of this potential storm, plan […]